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ABSTRACT 
This article presents a micro-manufacturing method for direct, projection printing of 3-
dimensional (3D) scaffolds for applications in the field of tissue engineering by using a 
digital micro-mirror-array device (DMD) in a layer-by-layer process. Multi-layered 
scaffolds are microfabricated using curable materials through an ultraviolet (UV) 
photopolymerization process. The pre-patterned UV light is projected onto the photocurable 
polymer solution by creating the “photomask” design with graphic software. Poly (ethylene 
glycol) diacrylate (PEGDA), is mixed with a small amount of dye (0.3 wt %) to enhance the 
fabrication resolution of the scaffold. The DMD fabrication system is equipped with a 
purging mechanism to prevent the accumulation of oligomer, which could interfere with the 
feature resolution of previously polymerized layers. The surfaces of the pre-designed, 
multi-layered scaffold are covalently conjugated with fibronectin for efficient cellular 
attachment. Our results show that murine marrow-derived progenitor cells successfully 
attached to fibronectin-modified scaffolds. 
INTRODUCTION 
Freeform fabrication technology [1-10] has become a very useful tool for the 
manufacturing of biological scaffolds for tissue regeneration and stem cell engineering [10-
13] due to the efficient and simple process for creating three-dimensional (3D) 
microstructures. Pre-designed, complex, 3D geometry in the micro- and nanometer scale 
can be created using polymeric materials without the use of lithographical masks or 
mechanical molds. The resolution given by DMD projection printing (DMD-PP) can create 
micro-pores comparable to the size of biological cells, i.e., micrometers. Depending on the 
number of pixels in a micromirror array, a DMD based system is capable of simultaneously 
forming structures in an area of several centimeters. The high resolution and fast fabrication 
speed make the DMD based system one of the most promising technology for fabricating 
tissue engineering scaffolds. 
In a typical process of DMD-based fabrication, a biological scaffold is formed on a 
moving-stage placed in a vat of photocurable monomer. The micro-mirror array from the 
DMD chip forms a pattern, created by graphic software, forming the geometry of a single 
layer for the 3D scaffold. An ultraviolet (UV) light source illuminates the micromirror-
array, and the illuminated pattern is projected, through an optical lens, onto the surface of 
the photo-curable monomer to form a single-layered structure. After one layer of monomer 
is selectively cured, the stage moves downward, as a new layer of monomer is formed 
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above the previously cured layer.  The cross-section pattern can be changed in between 
scaffold layers, and the process is repeated until the entire scaffold is formed. 
The DMD-based fabrication process is, however, challenged by deep UV penetration in 
the solution and unwanted light-scattering. The curing depth of the UV light could be too 
deep such that previous layers are affected by the current photo-pattern being displayed. 
UV-light scattering by previously formed microstructures may polymerize the monomer 
within the previous layers, causing a lost in feature resolution during the fabrication 
process. Lowering the UV intensity could fix these problems, but it could also degrade the 
resolution of the exposure layer. These problems became limiting factors to fabrication in 
our previous study [1]. 
Scattering and penetration problems can be resolved by mixing UV dyes into 
photocurable monomers prior to irradiation. The function of the UV dye can be understood 
through Beer’s Law [14]. Assuming that a monomer has an absorption constantα and a UV 
light intensity, , the UV intensity becomes at a depth z to give the following: I
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Figure 1A shows the exponential decay of light intensity as z increases.  is a 
threshold intensity at which the monomer starts to cure. CD is the curing depth, 
. When the UV dye is added, 
CureI
CureICDI =)( α  becomes larger (α′ ) and CD becomes smaller 
(CD’); the addition of the UV-dye to the monomer increases the absorption constantα and 
decreases the curing depth, and the structural resolution is therefore enhanced. Figures 1B 
and 1C show the patterned-polymerization of honeycomb-shaped structures with and 
without dye addition. In the absence of UV dye (Figure 1B), the monomer within the pores 
was partially cured by undesired scattering, and the structure had decreased resolution.  
With a small amount of dye in the same monomer solution, (Figure 1C), the structure is 
polymerized with increased resolution. 
Another challenge encountered with the DMD system is the accumulation of oligomers 
within previously polymerized layers of the multi-layered construct.  These oligomers are 
partially cured monomers, weakly cross-linked by unwanted scattered and penetrating UV 
light. To overcome this problem, it is necessary to purge the structure with new monomer 
solution between scaffold layers during the fabrication process. 
In this research, we built multilayered 3D structures for cellular behavior studies and for 
tissue engineering applications using the DMD-based fabrication system. The monomer that 
forms the scaffold was loaded with a small amount of UV absorbing dye to enhance the 
structural resolution. Our fabrication equipment also includes a simple purging system to 
prevent the accumulation of oligomers.  Upon fabrication, scaffolds were biologically 
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modified for cell attachment.  We show the intricate architecture of the 3D scaffold and also 
demonstrate efficient cell attachment within the porous tissue engineering construct. 
THE DMD PROJECTION PRINTING SYSTEM 
This scaffold fabrication system (Figure 2A) consists of a vat containing the polymer, a 
servo-stage (CMA-25-CCCL & ESP300, Newport) that supports the construct, a syringe 
pump, a DMD system (Discovery 1100, Texas Instruments), a UV lamp (200W, S2000, 
EXFO), and a fixed-focal lens (Edmond Optics). The syringe pump is created by 
connecting a 3mL disposable syringe barrel to the servo-stage and is used to inject fresh 
photocurable monomer solution to an outlet located on the stage.  The pump is 
automatically operated and is used in between layer fabrication.  The DMD chip is 
composed of an array of micro-mirrors that project the patterned photomask onto the 
photocurable monomer.  These micro-mirrors are illuminated by the UV light from the lamp 
using an 8mm light guide, and the fixed focal lens focuses and projects the images onto the 
translational stage.  The moving-stage, syringe-pump, DMD system, and the UV lamp are 
connected to a personal computer, and the DMD-base system is controlled through a driver 
interface supplied by Texas Instruments. 
SCAFFOLD FABRICATION 
Preparation of the Photocurable Monomer 
 
 
Figure 1. The curing of monomer with and without the addition of the UV dye, under the same intensity 
of exposure, (A) Theoretical model: The curing depth CD decreases when the absorption constant is 
increased after the addition of dye. (B) Photo-patterning of poly(ethylene glycol) diacrylate on a glass 
slide. The pores of a honeycomb structure are sealed by unwanted curing caused by scattered light. (C) 
Patterning the same monomer with the addition of UV dye TINUVIN 234 at a concentration of 0.2wt%. 
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The geometry of the honeycomb structure had increased feature resolution. 
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Figure 2. The schematics of the DMD fabrication system showing the fabrication scheme (A-C), and the 
patterns of the scaffold cross-section (inset). (A) The forming of one structural layer by a patterned UV- 
cross-section image. (B) A purging process to remove partially cured monomer. (C) Forming the next 
structural layer; the stage is positioned 50 um below the liquid surface to define the thickness of a new layer.  
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Perflorohexane (99.5%) and poly (ethylene glycol) diacrylate (PEGDA, Mn 258) were 
purchased from Sigma-Aldrich and used as received. Methacrylic acid (MAA) from Sigma-
Aldrich was distilled before use to remove inhibitors. The photo-initiator, Irgacure 2959, 
and UV dye, TINUVIN 234, were provided by Ciba Chemistry; both chemicals were used 
without further purification. 
To prepare the photocurable monomer solution, 10 wt% of Irgacure 2959 and 0.2 wt% 
of TINUVIN 234 were added into a 4:1 (volume ratio) mixture of PEGDA and MAA. The 
monomer solution was sonicated for 30 minutes and degassed for 15 minutes. 
Pre-Designed Scaffold Fabrication 
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Figure 3. SEM pictures (Figure 3A-C) and fluorescence (Figure 3D) micrographs show that the D1 cells 
attach and secrete extracellular matrix onto the surfaces of the fibronectin-modified scaffold. 
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The polymer vat was filled with perfluorohexane (C F6 14), an inert chemical with high 
density (1.685 g/cm3) and a molecular polarity significantly lower than the photo-curable 
monomer.  Because of these properties, the photocurable monomer forms a layer on top of 
perfluorohexane within the polymer vat. The majority of the stage is immersed in 
perfluorohexane.  A key advantage of using an inert, heavy liquid like perfluorohexane is 
that only a small amount of photocurable monomer solution is necessary during fabrication 
as the perfluorohexane acts as a “filler” material for the bottom region of the stage.  The 
syringe pump was also filled with perfluorohexane to be used as the purging agent.  The 
focal plane of the DMD-PP was determined, and the stage was set accordingly. The height 
of the polymer vat was adjusted to allow a thin layer of the photocurable monomer to form 
on the outlet of the syringe pump.  A UV photomask from the DMD system selectively 
solidifies the monomer into a thin layer, creating the first layer of the structure. The shape 
of the outlet was properly designed, such that the scaffold layers completely cover the 
outlet. 
The power of the UV image was determined to be approximately 5mW/cm2, and UV 
exposure time was set for 60 seconds. After the first layer was built (Figure 2B), the stage 
moves the structure below the perfluorohexane/monomer interface, and the syringe pumps 
perfluorohexane through the microstructure on the outlet. The perfluorohexane solution 
pushes the uncured material (which includes oligomers) back to the monomer layer. After 
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the purging step, the stage moves up and locates the top of the structure slightly higher than 
the perfluorohexane/monomer interface. The syringe aspirates monomer at a volume equal 
to the amount purged by perfluorohexane, and the structure is filled with fresh monomer. 
Following this step, the stage moves to 50 µm below the position where the previous layer 
was created (Figure 2C), and the next layer is then created. The patterned-polymerization 
and purging cycles are repeated until the entire, pre-designed scaffold is built. 
As shown in the inset of figure 2, we used three different cross-sectional images (1-3) to 
pattern the scaffold with hexagonal-shaped porosity. The images were used in a sequence: 
1-1-1-2-1-1-1-3-1-1-1-2-1-1-1-3-1. The layered structure of the scaffold includes four 
honeycomb layers, neighboring honeycomb layers are spaced by three rectangular rims, and 
the space between two honeycomb layers was measured to be 150 µm. 
By using UV dye TINUVIN 234, we successfully adjusted the curing depth of 
monomer to about 50 µm. There is little scattering interference between the new layer and 
previously formed layer.  Under a brightfield microscope, we found that the geometry of 
each of the honeycomb layers was clearly defined, and the pores of the honeycomb 
structures were free from unwanted polymerization or oligomer accumulation. 
 
Surface Modification of the Preformed Scaffold with Fibronectin 
After the scaffold was fabricated, tethered carboxyl groups from the methacrylic acid 
(pre-mixed in the monomer) was activated using 1-ethyl- 3- [3-dimethylaminopropyl] 
carbodiimide hydrochloride/ N- hydroxysulfosuccinimide chemistry (EDC/ sulfo-NHS, 
Pierce Technologies, Rockford, IL).  EDC is a commonly used crosslinker in 
bioconjugation chemistries to create amide bonds.  Carboxyl groups are converted to 
amine-reactive sulfo-NHS esters by EDC with the presence of sulfo-NHS.  0.4M EDC and 
0.4M sulfo-NHS in 0.1M MES buffer [(2-(N-morpholino) ethane sulfonic acid), pH 6.5], 
were added to the scaffolds at a total volume of 1.5 mL and incubated on a rotator for 2 h at 
room temperature.  Using a low-affinity microcentrifuge tube, a 1.5 mL solution of 
fibronectin (10 g/mL) was then added to the scaffolds upon carboxyl activation, and 　
incubated at room temperature for a 24 h period.  Scaffolds were then sterilized using 70% 
ethanol for 30 minutes prior to cell seeding, and rinsed several times with PBS to remove 
unconjugated fibronectin and ethanol. 
 
Murine Marrow-derived Progenitor Cells 
A bone marrow progenitor cell line derived from mice, D1 ORL UVA (ATCC, 
Manassas, VA), was seeded onto the fibronectin-modified scaffolds created by the DMD-
based system. Prior to seeding the cells onto the scaffolds, an amine-reactive fluorescent 
dye, CellTrace™ Far Red DDAO-SE (Molecular Probes, Eugene, OR) was used to stain the 
cells red, following the manufacturer’s protocol.  Scaffolds were placed on sterilized 
parafilm within a tissue culture plate and then suspended in primary medium that contained 
250,000 D1 cells.  The suspended cell solution forms a “ball” on top of the scaffold, thereby 
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localizing the cells onto the fibronectin-modified scaffold, due to the hydrophobic surface 
of the parafilm.  After a 4 h seeding period, the rest of the primary medium was added to 
the tissue culture plate.  Primary medium used to culture D1 was composed of 10% w/v 
FBS (ATCC) and 1% w/v penicillin streptomyocin in Dulbecco’s Modified Eagle’s Medium 
(ATCC).  The cell-scaffold construct was placed in a humidified incubator (5% CO2, 37°C) 
and kept in culture for a 48 h period before fixing in a 10% formalin solution.  Scaffolds 
were then prepared for scanning electron and fluorescence confocal microscopic analyses.  
Scanning electron (Figure 3A-C) and fluorescence (Figure 3D) micrographs show that 
D1 cells attach and secrete extracellular matrix onto the surfaces of the fibronectin-
modified scaffold.  Fibronectin is a highly characterized protein known to bind to cell 
integrins, causing cell anchorage onto surfaces bound to this particular protein.  Figure 3D 
is a three-dimensional compiled fluorescence micrograph of attached cells created from 
individual images obtained through confocal microscopy.  The scaffold depicted here is 
composed of four layers with a wall thickness of 50 µm and a hexagonal pore geometry of 
approximately 150 µm. 
CONCLUSION 
A porous, multilayered, 3D scaffold for studies in cellular behavior was successfully 
created by patterning a photocurable monomer using a DMD-based fabrication tool. The 
monomer includes a small amount of absorbing dye (TINUVIN 234, 0.2wt%) which 
enhances the geometric resolution of the scaffold and reduces the curing depth of the 
monomer. The fabrication tool also includes a perfluorohexane-based purging mechanism 
to remove oligomers within the pores of the curing structure. The surfaces of the 3D 
scaffolds were biochemically modified with fibronectin for efficient cellular attachment. 
Data from SEM and confocal fluorescence micrographs confirm the successful seeding, 
attachment, and proliferation of D1 cells onto these pre-designed, micro-fabricated porous 
structures. 
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